Bausch + Lomb sells contact lenses, eye drops and other products that generate a steady revenue stream. Bausch Health’s main drug, the gut antibiotic Xifaxan, will likely face generic competition in ...

It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products.

Twenty-one months into his second tenure as CEO of Bausch + Lomb, serial dealmaker Brent ... The company, which sells contact lenses and eye care products, has issued a statement saying that ...

over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint ...

Products are available through a customizable catalog on Opal, including Bausch + Lomb contact lens brands such as Bausch + Lomb INFUSE®, Bausch + Lomb ULTRA® and Biotrue® ONEday. Over-the ...

“Opal is an all-in-one digital platform that offers faster, more convenient ordering of Bausch + Lomb products, helping to save staff time, boost patient loyalty and reduce the administrative ...

Bausch + Lomb sells contact lenses, eye drops and other products that generate a steady revenue stream. Bausch Health’s main drug, the gut antibiotic Xifaxan, will likely face generic ...